CPGR Using Peptide Arrays to ID Antibodies for Use in Influenza Biomarker Panel | GenomeWeb

This story originally ran on June 24.

By Adam Bonislawski

South Africa's Centre for Proteomic and Genomic Research is developing high-density arrays of synthetic peptides in an effort to identify influenza antibodies that could serve as a biomarker panel for vaccine development.

In a project announced last week, CPGR is collaborating with scientists from the University of British Columbia to build a biomarker signature that could be used in the development of seasonal influenza vaccines.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.